Your session is about to expire
← Back to Search
EpiCare@Home for Seizures
Study Summary
This trial will study a device that monitors brain and physical activity to detect seizures in people with focal epilepsy. Participants wear it in the hospital and at home.
- Epilepsy
- Seizures
- Focal Seizures
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a known allergy to the materials used in the Byteflies Adhesives or any other biopotential electrode.You need to be observed in an EMU for at least 1 hour for medical reasons.Adults and adolescents who have a history or suspicion of focal onset epilepsy, including certain types of seizures.If you have certain implanted devices like pacemakers or cardioverter defibrillators that could be affected by magnets, you may not be able to participate. The risk will be looked at individually.
- Group 1: EpiCare@Home
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current count of participants in this experiment?
"Confirmed. The clinicaltrials.gov listing for this trial shows that it is currently recruiting participants and has been since January 23rd, 2023. 80 individuals need to be enrolled from 1 medical site; the last update was on February 10th, 2023."
Is this experiment open to enrollment at the present time?
"Affirmative. According to the information present on clinicaltrials.gov, this trial is currently open for recruitment and has been since an initial post date of January 23rd 2023. The study's last edit was February 10th 2023 with a goal of recruiting 80 participants from 1 medical centre."
What is the overarching objective of this research endeavor?
"This clinical trial intends to measure the sensitivity of algorithmic detection of potential epileptic events in EpiCare@Home study participants over a 10 day period as compared with video-EEG ground truth annotations. Other objectives include calculating sensitivity and specificity from seizure diary entries, evaluating the effect of seizure origin on data recall accuracy, and assessing interrater reliability (IRR) among trained reviewers."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger